
Precision BioSciences, Inc.: updates and filings
Price
$7.40
November 20, 2026Market cap $207M
What Ploutos Investor adds for Precision BioSciences
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 3, 2026next Feb 4, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
July 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 9, 2026Other material eventsForm8-K
- Nov 6, 2026Other material eventsForm8-K
- Nov 5, 2026Regulation FD disclosure, other material eventsForm8-K
- Nov 3, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 3, 2026Results of operationsForm8-K
- Nov 3, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 27, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 24, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 24, 2026Regulation FD disclosure, other material eventsForm8-K
- Aug 7, 2026Shares registered for employeesFormS-8
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jul 29, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 27, 2026Officer or director change, Regulation FD disclosureForm8-K
- Jul 20, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 1, 2026Regulation FD disclosure, other material eventsForm8-K
- Jun 16, 2026Material agreement entered, new material financial obligationForm8-K
- May 27, 2026Regulation FD disclosure, other material eventsForm8-K
- May 26, 2026Officer or director change, amended articles or bylaws, shareholder voteForm8-K
- May 5, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 5, 2026Results of operationsForm8-K
- Apr 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Apr 8, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 8, 2026Additional annual meeting materialFormDEFA14A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 9, 2026 | 8-K | Other material events | Document |
| Nov 6, 2026 | 8-K | Other material events | Document |
| Nov 5, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Nov 3, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 3, 2026 | 8-K | Results of operations | Document |
| Nov 3, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 27, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 24, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 24, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Aug 7, 2026 | S-8 | Shares registered for employees | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jul 29, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 27, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Jul 20, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 1, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Jun 16, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| May 27, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| May 26, 2026 | 8-K | Officer or director change, amended articles or bylaws, shareholder vote | Document |
| May 5, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 5, 2026 | 8-K | Results of operations | Document |
| Apr 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Apr 8, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 8, 2026 | DEFA14A | Additional annual meeting material | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Mar 15, 2006.
The full analysis
What do Precision BioSciences's filings show?
The filings are where every one of Precision BioSciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.